Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2001
01/17/2001EP1015430A4 Spiro pyrrolidine-2,3'-oxindole] compounds and methods of use
01/17/2001EP1003501A4 Means of ascertaining an individual's risk profile for atherosclerotic disease
01/17/2001EP0970365A4 Apparatus and methods for capture and analysis of particulate entities
01/17/2001EP0882226A4 Electrochemical method
01/17/2001EP0788555B1 Methods of analysis and manipulation of dna utilizing mismatch repair systems
01/17/2001EP0589982B1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i)
01/17/2001EP0539495B1 Device and method for measuring hdl-cholesterol employing precipitation on a solid-phase
01/17/2001CN2415376Y Apparatus for testing time of activating whole blood coagulation
01/17/2001CN2415356Y Tube type micro liquid distributor for making biological water
01/17/2001CN1280673A Improved electrochemical biosensor test strip
01/17/2001CN1280670A A Sampling device for thermal analysis
01/17/2001CN1280627A Proteinase inhibitor fusion proteins
01/17/2001CN1280623A Method and compositions useful for activation of silent transgenes
01/17/2001CN1280620A Antigen protein and nucleic acid coding for said protein
01/17/2001CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
01/17/2001CN1280618A Protein involved in abscisic acid signalling
01/17/2001CN1280611A Method and compositions for binding hematopoietic stem cells
01/17/2001CN1280483A Site-specitic preparation of polyethylene glycol-GRF conjujates
01/17/2001CN1280299A Central identifying for nucleic acid samples and method for result feedback
01/17/2001CN1060861C Flow colorimeter cup for biochemical enalyzer
01/16/2001US6175409 Flow-injection analysis and variable-flow light-scattering methods and apparatus for characterizing polymers
01/16/2001US6175408 Apparatus for detecting foreign substance in strand-like textile material
01/16/2001US6175111 Method for diagnosis of components inside turbine generator
01/16/2001US6175016 Such as 3-hydroxy-1-(5-amino-5-carboxy-pentyl)-4-(1-amino-1-carboxy-2-ethyl)-5-(3 -amino-3-carboxy-propyl) pyridinium hydrochloride; making via cyclization reaction; for use in diagnosing bone and connective tissue disorders
01/16/2001US6174994 7TM receptor (H2CAA71)
01/16/2001US6174872 Immunotherapy of allergic asthma in both its early and late stages by administering to the mucosa a polynucleotide encoding an asthma-initiating antigen and immunostimulatory neucleotide seqence stimulating the th1 lymhocytes
01/16/2001US6174740 Applying mechanical damage onto surface of silicon wafer to form distortions; oxidizing to form thermal oxide film on wafer surface; dissolving thermal oxide film with chemical solution or vapor; determining bulk impurities
01/16/2001US6174734 Measurement of glycated hemoglobin
01/16/2001US6174733 Detection of pathogens using a column device with a sample containing a control
01/16/2001US6174732 Analytical methodology for qualitative and quantitative determination of chemical agent vapor
01/16/2001US6174731 Reagent for the PH-metric determination of low acid numbers in petroleum oils
01/16/2001US6174729 Accurate, simple method by applying protein solution to porous support, solution diffuses in presence of detergent and salt and/or acid to form uniform spot, measuring size of spot, comparing to standard
01/16/2001US6174728 Scattering calibration particles dispersed in aqueous electrolyte solution; particles have mean diameter of less than 0.06 micrometers and volume concentration of less than 0.3 %; nonsettling; storage stability
01/16/2001US6174727 Method of detecting microscopic defects existing on a silicon wafer
01/16/2001US6174723 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody
01/16/2001US6174714 Lyss
01/16/2001US6174700 Purification of a polypeptide compound having a polysaccharide binding domain by affinity phase separation
01/16/2001US6174698 Applying precise, focused energy to photoactivate; testing fragility
01/16/2001US6174696 Method for the determination of homocysteine
01/16/2001US6174694 Phosphorylation of serine containing substrate; incubate substrate with adenosine triphosphate and a enzymatic protein, monitor the amount of phosphorylation
01/16/2001US6174693 Immunological assay for protein activity
01/16/2001US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding
01/16/2001US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance
01/16/2001US6174690 Detecting sodium channel modulators; incubate cells expressing sodium channels with indicator and monitor suspension for color, change in color is indicative of activation by modulators
01/16/2001US6174688 Immunoassay; mix antibody and control sample, mix second control sample, modulator and antibody, incubate sample and antibody, incubate sample, modulator and antibody, compare control and sample values, count antigen and modulator
01/16/2001US6174687 Methods of identifying lung homing molecules using membrane dipeptidase
01/16/2001US6174686 Detecting muscle protein isoforms in blood sample; incubate blood sample with suppressor which dissociates complexed mucsle protein isoforms, incubate sample with antibody specific for muscle protein, detect signal from antibody
01/16/2001US6174685 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
01/16/2001US6174683 Immobilization of biomolecular probes by using derivatized polyurethane-based hydrogels; stability, genetic engineering
01/16/2001US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases
01/16/2001US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning
01/16/2001US6174670 Achieved with rapid thermal cycling and use of double stranded dna dyes or specific hybridization probes
01/16/2001US6174667 Bovine viral diarrhea virus serum antigen capture
01/16/2001US6174665 Monitoring treatment of menopause; obtaining a body fluid sample and counting amount of progesterone, testosterone, estradiol, follicle stimulating hormone, and estriol, administering and adjusting compounds as needed
01/16/2001US6174664 Screening method for inflammatory diseases using neutrophil defensins and lactoferrin
01/16/2001US6174497 Detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form
01/16/2001US6174066 Light device for verifying the possible presence of solid deposits and other impurities inside a bottle of wine
01/16/2001CA2313860A1 Initiation of an analytical measurement
01/16/2001CA2206602C Sequential delivery of purified biological and chemical reagents
01/16/2001CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
01/16/2001CA2164707C Technetium-99m labeled peptides for imaging inflammation
01/16/2001CA2138536C Chemiluminescent assay for dsdna antibodies
01/16/2001CA2029861C Diagnosis and treatment of insulin dependent diabetes mellitus
01/16/2001CA2029488C Prevacuum steam sterilization test pack
01/16/2001CA2010800C Protein labelling
01/16/2001CA1341170C Calcium channel compositions and methods
01/15/2001CA2277596A1 Improved surface ionization detector
01/14/2001CA2313869A1 Genotyping biallelic markers
01/14/2001CA2313863A1 Use of hemoglobin derivatives for determining plasma and/or blood volume
01/11/2001WO2001002866A1 Diagnostics and therapeutics for arterial wall disruptive disorders
01/11/2001WO2001002865A1 Cyclotron mass spectrometry screening
01/11/2001WO2001002864A1 Methods and kits for diagnosing or monitoring a synovial or osteoarticular pathology comprising the use of a specific marker of the synovial tissue degradation
01/11/2001WO2001002863A1 Diagnostic assay for human matrix gla-protein and its use as a biomarker
01/11/2001WO2001002862A1 Methods to detect protein trafficking disorders
01/11/2001WO2001002861A1 Detection using dendrimers bearing labels and probes
01/11/2001WO2001002860A1 Snail, new tumoral progression marker and target protein of new antitumoral compounds
01/11/2001WO2001002858A1 Immuno-diagnostic test method for veterinary disease
01/11/2001WO2001002857A1 Measurement and use of molecular interactions
01/11/2001WO2001002856A1 Method for determination of peptide-binding agent interaction
01/11/2001WO2001002855A1 Prevention and treatment of amyloid-associated disorders
01/11/2001WO2001002854A1 Analyte detection
01/11/2001WO2001002853A2 DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY
01/11/2001WO2001002852A1 Test method for evaluating soluble polymer growth when recycling inhibitor streams
01/11/2001WO2001002851A1 Method for screening targeting dds preparation
01/11/2001WO2001002848A1 Method for the multi-dimensional analysis of a proteome
01/11/2001WO2001002841A1 Method of measuring consistency of a web, and a measuring device
01/11/2001WO2001002835A1 Method for quantitation of endothelial microparticles
01/11/2001WO2001002834A1 Micro-fabricated solubility measuring system and a method for determining the solubility of a sample
01/11/2001WO2001002833A1 Method and arrangement for measuring characteristics of a non-newtonian fluid
01/11/2001WO2001002831A1 Method and apparatus for measuring retention of a substance
01/11/2001WO2001002828A2 Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides
01/11/2001WO2001002609A2 Method of identifying toxic agents using differential gene expression
01/11/2001WO2001002604A1 Use of the krit1 gene in angiogenesis
01/11/2001WO2001002600A2 Detection of analytes using attenuated enzymes
01/11/2001WO2001002599A2 Assay method to identify s-phase cells on cell sections or permeabilised cells and uses thereof
01/11/2001WO2001002598A2 Screening for compounds modulating mitochondrial proton leak
01/11/2001WO2001002587A2 Novel antifungal agents and fungicides, method for the production thereof and their use
01/11/2001WO2001002583A2 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins
01/11/2001WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof
01/11/2001WO2001002569A2 Human immune response molecules